Israel’s national life science and technology week to be held on May 24-26, 2016 at the David InterContinental Hotel in Tel Aviv
TEL AVIV, ISRAEL – March 7, 2016 – Israel’s premier international biomed conference and exhibition, IATI-Biomed, will celebrate its 15th anniversary between May 24-26, 2016, at the David InterContinental Hotel in Tel Aviv, Israel.
As the leading event of Israel’s life sciences industry, IATI-Biomed has positioned itself throughout the years as the main annual meeting place for healthcare professionals from Israel with their colleagues and partners from around the globe. Visitors from across the world will explore the various innovations, and experience firsthand the entrepreneurial spirit which is a basis of Israel’s vibrant life science community. Previous successful conferences hosted over 6,000 industry senior executives, scientists, and engineers, including approximately 1,000 participants from over 45 countries and in excess of 4,500 one-on-one meetings.
Ruti Alon, IATI-Biomed Co-Chairperson and General Partner, Pitango Venture Capital, said, “It is with great pleasure that I invite members of the life science ecosystem from around the world and Israel to come celebrate with us our 15thanniversary. This year we’re introducing a new and exciting format that will enhance interactions between young and mature companies and old and new friends in specific fields of interest with the goal of paving the way for new business collaborations. Participants will be able to enjoy roundtable discussions, panel presentations, networking opportunities and product demonstrations, exploring innovation and trends that are shaping the future of healthcare systems and the life science ecosystem.”
This year the conference will be organized in a new format and will be divided into the following 9 tracks:
- The Promise of Immuno-oncology
- Robotics’ Role in Healthcare
- Neurological Disorders
- Personalized Diagnostics, Precision Medicine and Biomarkers
- Cardiology, Listen to your Aching Heart
- From Academia to Industry
- Health IT
- The New “Kids” on the Block:
- Microbiome
- Gene Editing and Gene Therapy
- Early Stage Challenges and Opportunities
Dr. Benny Zeevi, IATI-Biomed Co-Chairperson and Managing General Partner, Tel Aviv Venture Partners, commented, “Israel has established itself as a leading center of innovation in biomedical research and development. The country’s entrepreneurial spirit together with its academic excellence continues to fuel the biomed industry, as it expands and matures. Notable in recent years is the advancements in the area of health IT, which is based on Israel’s strength in computer science and engineering, combined with its advanced digital healthcare systems.”
Among the conference’s speakers are:
- Assaf Barnea, CEO, Sanara Ventures
- Dr. Arie Belldegrun, Chairman, President & Chief Executive Officer, Kite Pharma Dr Miro Venturi Global Head Diagnostics, Roche
- Peter Bergethon, VP Head of Quantitative Medicine, Biotherapeutics, Pfizer
- Donald E. Bobo, Jr. Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development Edwards Life Sciences
- Jason Coloma, Vice President, Global Head, Roche Partnering Oncology
- Deborah DiSanzo, General Manager, IBM Watson Health
- Dr. Eran Eden, CEO and Co-Founder, MeMed
- Yael Glassman, President at Nutrino
- Dr. Yehoshua (Shuki) Gleitman, GIBF Fund
- Henry O. Gosebruch, Executive Vice President and Chief Strategy Officer, AbbVie
- Prof. Zamir Halpern, Tel Aviv Sourasky Medical Center
- Dr. Rachel Humphrey, Chief Medical Officer, CytomX Therapeutics
- Richard W. Joseph, MD, Mayo Clinic
- Manish Kohli, MD, Mayo Clinic
- Dr. Jay Kranzler, Vice President and Head, BioTherapeutics and WRD Strategic Investments, External R&D Innovation at Pfizer
- Prof. Amir Lerman, Division of Cardiovascular Diseases and Internal Medicine at the Mayo Clinic
- Dr. Marie Lindner, Global Program Head, Strategic Partnership Team, Novartis
- Prof. Gal Markel, Sheba Medical Center, and Tel Aviv University
- Francois Maisonrouge, Senior Managing Director at Evercore Partners
- Dr. Anthony Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi
- Shlomo Nimrodi, CEO, Ramot at Tel Aviv University
- James Rogers, Chair, Mayo Clinic Ventures
- Dr. Bruce R. Rosengard, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies
- Michal Rosen-Zvi, Director, Health Informatics, IBM Research
- Dr. Luisa Salter-Cid, Vice-President Immunoscience, Bristol-Myers Squibb
- Prof. Michal Schwartz, Weizmann Institute of Science
- Patrick Terry, President, GMPO Orphan
- Miro Venturi, Global Head Diagnostics Biomarkers, Roche
- Prof. Alon Wolf, Technion, Israel Institute of Technology
For the preliminary program:
http://kenes-exhibitions.com/old/biomed2016/conference/preliminary-program/.
About IATI-Biomed
For the 15th consecutive year, IATI-Biomed is the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such, this world-class event presents an opportunity for global participants to experience Israel’s life science innovation and vibrant biomedical industry at its best. Previous successful conferences hosted over 6,000 industry players, scientists and engineers including more than 1,000 attendees from over 45 countries that participated in over 4,500 one-on-one meetings. Hundreds of Israeli life science companies will present and exhibit their products, services and technologies allowing for hands-on experience. For additional information, please visit our website at: http://kenes-exhibitions.com/old/biomed2016/.
http://www.businesswire.com/news/home/20160307005787/en/IATI-Biomed-Israel%E2%80%99s-Leading-Life-Science-Conference-Celebrates
